Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 10, 2016 5:40 PM ET

Healthcare Providers and Services

Company Overview of University Hospitals Cleveland Medical Center Inc.

Company Overview

University Hospitals Cleveland Medical Center Inc., doing business as University Hospitals Case Medical Center, operates a tertiary medical center specializing in adult/pediatric medical and surgical specialties. Its services include cancer care, digestive health care, heart and vascular care, neurology and neurosurgery, obstetrics and gynecology, ophthalmology and dermatology, orthopedics and spine, otolaryngology, pediatrics, surgery, transplant, and urology. The company also provides services in the areas of women’s health, radiology and radiation oncology, cardiology and cardiothoracic surgery, organ transplantation and infectious diseases, behavioral health, and human genetics and genom...

11100 Euclid Avenue

Cleveland, OH 44106

United States

Founded in 1988

Phone:

216-844-1000

Fax:

216-844-7497

Key Executives for University Hospitals Cleveland Medical Center Inc.

Chief Executive Officer
Age: 60
President and Chief of Cardiovascular Medicine
Chief Operating Officer
President of The UH Seidman Cancer Center
Chairman of the Department of Pediatrics at Rainbow Babies & Children's Hospital
Compensation as of Fiscal Year 2015.

University Hospitals Cleveland Medical Center Inc. Key Developments

University Hospitals Case Medical Center Announces Executive Changes

University Hospitals Case Medical Center has appointed Daniel I. Simon, MD, as the academic medical center's new President effective Jan. 1, 2016. In a release, University Hospitals noted that Dr. Simon will succeed Fred C. Rothstein, MD, who announced his retirement this summer after serving as President of UH Case Medical Center. University Hospitals reported that Dr. Simon is a leader in the field of cardiology. He has enhanced the prominence of UH Harrington Heart & Vascular Institute, where he has served as Director since 2006 and as President since 2014.

University Hospitals Case Medical Center Announces Executive Changes, Effective Jan. 1, 2016

University Hospitals Case Medical Center has appointed Daniel I. Simon, MD, as the academic medical center's new President effective Jan. 1, 2016. Dr. Simon will succeed Fred C. Rothstein, MD, who announced his retirement this summer after serving as President of UH Case Medical Center and one of the leader at the health system for the past 12 years. Dr. Simon is a leader in the field of cardiology. His dynamic leadership qualities and collegial style have enhanced the prominence of UH Harrington Heart & Vascular Institute, where he has served as Director since 2006 and as President since 2014. Throughout his tenure, he and his team have developed and executed growth, business and clinical strategies to enhance patient access, clinical integration and quality outcomes. Additionally, he has served as Chief of the Division of Cardiovascular Medicine at UH Case Medical Center and Professor of Medicine at Case Western Reserve University School of Medicine. He also holds the Herman K. Hellerstein, MD, Chair in Cardiovascular Research at UH Case Medical Center and the School of Medicine. Dr. Simon is an active interventional cardiologist and continues to play a leading role in national and international clinical trials investigating new devices, anti-thrombotic drugs, and regenerative medicine/adult stem cell therapies.

University Hospitals Case Medical Center Presents New Results from Systolic Blood Pressure Intervention Trial

University Hospitals Case Medical Center presented new results from the Systolic Blood Pressure Intervention Trial (SPRINT) showing that in patients at high risk for cardiovascular events, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of fatal and non-fatal major events or death compared to targeting systolic blood pressure to the usually recommended target of less than 140 mm Hg. The findings presented at the American Heart Association (AHA) Scientific Sessions in Orlando and published in the New England Journal of Medicine (NEJM) add to the preliminary results from SPRINT announced two months ago. These findings demonstrated intensive management of high blood pressure, below a commonly recommended blood pressure target, significantly reduces rates of cardiovascular disease, and lowers risk of death in a group of adults 50 years and older with high blood pressure. The SPRINT study, a landmark clinical trial sponsored by the National Institutes of Health, has evaluated the benefits of maintaining a new target for systolic blood pressure, the top number in a blood pressure reading, among a group of patients 50 years and older at increased risk for heart disease or who have kidney disease. University Hospitals Case Medical Center/Case Western Reserve University School of Medicine coordinated one of the five Clinical Center Networks (CCNs) across the country selected to conduct the trial that has recruited more than 9,300 participants. This blood pressure intervention portion of the trial was stopped 3.26 years into a planned 5-year term as a result of the finding of a 25% reduction in the primary cardiovascular outcome and 27% reduction of all-cause mortality in those randomized to the lower 120 mm blood pressure target. Specifically, a 38% reduction in heart failure and 43% reduction in death from heart-related events was found and reported in NEJM. The study reported about 1% to 2% higher rates of adverse events such as hypotension, syncope, electrolyte abnormalities and acute kidney injury/failures in the group of patients treated to the lower systolic blood pressure target. As a continuation of these findings, SPRINT researchers are proceeding to examine how the lower systolic blood pressure target may impact the incidence of dementia and long-term kidney disease. In order to achieve the 120 mm target, the findings also noted that an average of one additional medication was required for the lower target with no difference in tolerability even in patients over age 75.

Similar Private Companies By Industry

Company Name Region
Seton McCarthy Community Health Center United States
Housecall Medical Resources, L.L.C. United States
Golden Plains Community Hospital United States
CIGNA HealthCare of Arizona, Inc. United States
Sophora Diagnostic Lab, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
August 31, 2015
St. John Medical Center
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact University Hospitals Cleveland Medical Center Inc., please visit www.uhhospitals.org/case. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.